November 18, 2009 - IVTM Added to FSS Contract


A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637


November 18, 2009CHELMSFORD, MASS.– ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that it has been awarded a modification contract from the U. S. Veterans Administration (VA) that adds the Company’s Intravascular Temperature Management (IVTM) systems to the Federal Supply Schedule (FSS).  Currently, the ZOLL technology is the exclusive intravascular temperature management solution available on the FSS contract. 

Under the terms of the five-year agreement, VA hospitals and all branches of military hospitals can order ZOLL’s IVTM against this contract, making the procurement of equipment easier without the need to go out for bid.  

“We are pleased that ZOLL has been selected, once again, to provide equipment on a continuing basis to our government’s medical facilities to help improve critical patient care for our veterans and service people,” said Richard A. Packer, Chairman and CEO of ZOLL.

ZOLL’s IVTM solutions provide the power and control to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients for a variety of indications.  Both the ZOLL CoolGard® and Thermogard XP® systems precisely control the patient’s temperature by accurately adjusting the internal temperature of the IVTM balloon catheter that is positioned within the patient’s blood vessel.  ZOLL’s extensive family of IVTM catheters are used to cool and warm patients depending upon the clinical need.

About ZOLL Medical Corporation

ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies.  With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the past three years, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2009. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, CoolGard and Thermogard XP are registered trademarks of ZOLL Medical Corporation. IVTM is a trademark of ZOLL Medical Corporation.